Skip to main content

Table 1 Baseline characteristics of participants

From: The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial

Baseline characteristics

Groups

 

Synbiotics

(n = 34)

Placebo

(n = 33)

P value

 

Age (years)

 

53.58 ± 11.34

51.00 ± 12.53

0.3902*

 

Education

illiterate

1 (%2.9)

0 (%0 )

0.0791

 

elementary

12 (%35.3 )

9 (%27.3)

 

High school

18 (%52.9)

13 (%39.4)

 

university

3 (%8.8)

11 (%33.3)

 

Disease history

none

30 (%88.2)

27 (%81.8)

0.4141

 

diabetes

2 (%5.8)

5 (%15.2)

 

dyslipidemia

2 (%5.9)

1 (%3)

 

Chemotherpy type

adjuvant

17 (%50)

19 (%57.6)

0.5341

 

Neuadjuvant

17 (%50)

14 (%42.4)

 

Occupation

Non-employee

25 (%73.5)

23 (%69.7)

0.7281

 

Employee

9 (%26.5)

10 (%30.3)

 

Smoking

yes

8 (%23.5)

5 (%15.2)

0.3861

 

No

26 (%76.5)

28 (%84.8)

 

Marriage

Single

5 (%14.7)

7 (%2.21)

0.4781

 

Married

29 (%85.3)

26 (%78.8)

 

Tumor Surgery

yes

17 (%50)

19 (%57.6)

0.5341

 

No

17 (%50)

14 (%42.4)

 
 

None

13 (%38.2)

9 (%27.2)

  

Supplements intake

Multivitamin

10 (%29.4)

8 (%24.2)

0.3291

 

Vitamin D

19 (%55.8)

20 (%60.6)

 
 

Calcuim

6 (%17.6)

9 (%27.2)

  

Medication (except for common medicines)

None

30 (%88.2)

27 (%81.8)

0.4141

 

Diabetes

2 (%5.9)

5 (%15.2)

 
 

Dyslipidemia

2 (%5.9)

(%3)

  

Chemotherapy session

Second

22 (%64.7)

20 (%60.6)

0.3491

 

Third

8 (%23.5)

5 (%15.2)

 

Forth

4 (%11.8)

8 (%24.2)

 
  1. Quantitative data reported as mean ± SD, and qualitative data reported as number (%)
  2. 1Between-group analysis conducted via chi-square test
  3. 2Parametric and non-parametric quantitative variables assessed via Independent-Samples T test ¥ or Mann-Whitney*, respectively